Digital Pharma Enablement Leveraging the Accelerator Drug Development framework and the mySupply platform for real time data visibility; this positions us to sell digital supply chain and data integration services to sponsors seeking faster development cycles and tighter trial oversight.

Cell Therapy Focus Active partnerships with Ethris, Cybin, RoosterBio, and MiraiBio indicate strong demand in gene and cell therapies; target biotech startups and established players needing GMP manufacturing, clinical supply, and eventual commercialization for viral vectors, cell therapies, and exosome platforms.

Capacity Expansion Recent facility expansions including pipette production capacity in strategic United States locations signal readiness to scale; present opportunities to win additional contract manufacturing, formulation, and logistics work for customers planning ramp ups and diverse modalities.

Global Network A worldwide network across the Americas, Europe, Asia, and Australia enables regional manufacturing and localized clinical supply and packaging; pitch as a global partner capable of multi region regulatory alignment and coordinated trials.

End to End Capabilities Patheon end to end pharma services from API to packaging and logistics supports sponsors seeking a single integrated partner to coordinate development, clinical supply, manufacturing, and commercialization, reducing vendor fragmentation and time to market.